DO
IONS icon

denkapparat Operations’s Ionis Pharmaceuticals IONS Stock Holding History

denkapparat Operations’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$663K Hold
8,364
– – 0.22% 188
2026
Q1 		$628K Hold
8,364
– – 0.26% 150
2025
Q4 		$662K Sell
8,364
-1,604
-16% -$121K 0.36% 107
2025
Q3 		$652K Buy
+9,968
New +$487K 0.42% 82

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

denkapparat Operations's IONS Position: Q2 2026 in Review

denkapparat Operations held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 8,364 shares worth $663K. The position accounts for 0.22% of the portfolio, ranked #188.

denkapparat Operations first reported a position in IONS in Q3 2025 and has held it in 4 quarters since. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • denkapparat Operations held 8,364 shares of Ionis Pharmaceuticals worth $663K as of Q2 2026.
  • denkapparat Operations left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
  • Ionis Pharmaceuticals made up 0.22% of denkapparat Operations's portfolio in Q2 2026, its #188 holding.
  • denkapparat Operations first reported a position in Ionis Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on denkapparat Operations's 13F filing for Q2 2026, filed 6 Aug 2026.